1-10 of 10
Robert Orlowski
Close
Sort by
Journal Articles

Characterizing Safety in Patients with Hematologic Malignancies Receiving Allogeneic Stem Cell Transplant (Allo-SCT) Following Pembrolizumab Therapy

Philippe Armand, John Kuruvilla, Alex F. Herrera, Vincent Ribrag, Pauline Brice, Catherine Thieblemont, Bastian Von Tresckow, Eunhee Kim, Robert Orlowski, Samhita Chakraborty, Patricia Marinello, Pier Luigi Luigi Zinzani
Journal: Blood
Blood (2021) 138 (Supplement 1): 3924.
https://doi.org/10.1182/blood-2021-148528
Published: 2021
Journal Articles

PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell–inflamed phenotype

James Godfrey, Sravya Tumuluru, Riyue Bao, Michael Leukam, Girish Venkataraman, John Phillip, Carrie Fitzpatrick, James McElherne, Brendan W. MacNabb, Robert Orlowski, Sonali M. Smith, Justin Kline
Journal: Blood
Blood (2019) 133 (21): 2279–2290.
https://doi.org/10.1182/blood-2018-10-879015
Published: 2019
Includes: Supplemental data
Journal Articles

Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group

Pieter Sonneveld, Hervé Avet-Loiseau, Sagar Lonial, Saad Usmani, David Siegel, Kenneth C. Anderson, Wee-Joo Chng, Philippe Moreau, Michel Attal, Robert A. Kyle, Jo Caers, Jens Hillengass, Jesús San Miguel, Niels W. C. J. van de Donk, Hermann Einsele, Joan Bladé, Brian G. M. Durie, Hartmut Goldschmidt, María-Victoria Mateos, Antonio Palumbo, Robert Orlowski
Journal: Blood
Blood (2016) 127 (24): 2955–2962.
https://doi.org/10.1182/blood-2016-01-631200
Published: 2016
Includes: Supplemental data
Journal Articles

Integrated Immunological Analysis of the Bone Marrow Tumor Microenvironment in Myeloproliferative Neoplasms to Determine Potential Efficacy of Immune Checkpoint Blockade

Robert Orlowski, MD, Alexander Huang, Mercy Gohil, James Mangan, MD PhD, Marissa Vignali, PhD, Ryan O Emerson, PhD, Harlan Robins, PhD, Erik Yusko, PhD, Martha S Jordan, PhD, Martin Carroll, MD, D. Gary Gilliland, MD PhD, Elizabeth O Hexner, MD
Journal: Blood
Blood (2015) 126 (23): 2766.
https://doi.org/10.1182/blood.V126.23.2766.2766
Published: 2015
Journal Articles

IMWG consensus on maintenance therapy in multiple myeloma

Heinz Ludwig, Brian G. M. Durie, Philip McCarthy, Antonio Palumbo, Jésus San Miguel, Bart Barlogie, Gareth Morgan, Pieter Sonneveld, Andrew Spencer, Kenneth C. Andersen, Thierry Facon, Keith A. Stewart, Hermann Einsele, Maria-Victoria Mateos, Pierre Wijermans, Anders Waage, Meral Beksac, Paul G. Richardson, Cyrille Hulin, Ruben Niesvizky, Henk Lokhorst, Ola Landgren, P. Leif Bergsagel, Robert Orlowski, Axel Hinke, Michele Cavo, Michel Attal
Journal: Blood
Blood (2012) 119 (13): 3003–3015.
https://doi.org/10.1182/blood-2011-11-374249
Published: 2012
Journal Articles

International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation

Clinical Trials & Observations
Michele Cavo, S. Vincent Rajkumar, Antonio Palumbo, Philippe Moreau, Robert Orlowski, Joan Bladé, Orhan Sezer, Heinz Ludwig, Meletios A. Dimopoulos, Michel Attal, Pieter Sonneveld, Mario Boccadoro, Kenneth C. Anderson, Paul G. Richardson, William Bensinger, Hans E. Johnsen, Nicolaus Kroeger, Gösta Gahrton, P. Leif Bergsagel, David H. Vesole, Hermann Einsele, Sundar Jagannath, Ruben Niesvizky, Brian G. M. Durie, Jesus San Miguel, Sagar Lonial
Journal: Blood
Blood (2011) 117 (23): 6063–6073.
https://doi.org/10.1182/blood-2011-02-297325
Published: 2011
Journal Articles

Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

Clinical Trials & Observations
S. Vincent Rajkumar, Jean-Luc Harousseau, Brian Durie, Kenneth C. Anderson, Meletios Dimopoulos, Robert Kyle, Joan Blade, Paul Richardson, Robert Orlowski, David Siegel, Sundar Jagannath, Thierry Facon, Hervé Avet-Loiseau, Sagar Lonial, Antonio Palumbo, Jeffrey Zonder, Heinz Ludwig, David Vesole, Orhan Sezer, Nikhil C. Munshi, Jesus San Miguel, on behalf of the International Myeloma Workshop Consensus Panel 1
Journal: Blood
Blood (2011) 117 (18): 4691–4695.
https://doi.org/10.1182/blood-2010-10-299487
Published: 2011
Journal Articles

Targeting CDK9 Dramatically Potentiates ABT-737-Induced Apoptosis in Human Multiple Myeloma Cells through a Bim-Dependent Mechanism.

Yun Dai, MD, PhD., Shuang Chen, MD, PhD, Xin-Yan Pei, MD, Viswanathan Ramakrishnan, Ph.D, Michael Wang, MD, MS., Robert Orlowski, PhD, Paul Dent, PhD, Steven Grant, MD
Journal: Blood
Blood (2009) 114 (22): 297.
https://doi.org/10.1182/blood.V114.22.297.297
Published: 2009
Journal Articles

Initial Results of PX-171-004, An Open-Label, Single-Arm, Phase II Study of Carfilzomib (CFZ) in Patients with Relapsed Myeloma (MM)

Ravi Vij, MD, Michael Wang, MD, Robert Orlowski, MD, PhD, A. Keith Stewart, MBChB, Sundar Jagannath, MD, Vishal Kukreti, MD, FRCPC, Jessica Taylor, BA, Diana Fuhrman, BSN, Scott Cruickshank, MS, Richard Schwartz, MD, Lori Kunkel, MD, David Siegel, MD, PhD, The Multiple Myeloma Research Consortium (MMRC)
Journal: Blood
Blood (2008) 112 (11): 865.
https://doi.org/10.1182/blood.V112.11.865.865
Published: 2008
Journal Articles

Early Normalization of Serum Free Light Chain Is Associated with Prolonged Time to Progression Following Bortezomib ± Pegylated Liposomal Doxorubicin Treatment of Relapsed/Refractory Multiple Myeloma.

Robert Orlowski, MD, PhD, Heather Sutherland, MD, PhD, Joan Bladé, MD, Jesús San Miguel, MD, Roman Hájek, MD, PhD, Arnon Nagler, MD, MSc, Pieter Sonneveld, MD, PhD, Andrew Spencer, DM, Tadeusz Robak, MD, PhD, Suneel Mundle, PhD, Donghan Luo, PhD, Sen Hong Zhuang, MD, PhD, Jean-Luc Harousseau, MD
Journal: Blood
Blood (2007) 110 (11): 2735.
https://doi.org/10.1182/blood.V110.11.2735.2735
Published: 2007